HIV News and Research

RSS

Booster vaccination can reduce breakthrough infection risk in HIV patients

New study reveals that people with HIV are at a high risk of breakthrough COVID-19 infection in comparison to people without HIV, and that booster vaccinations can be protective for those living with HIV.

9 Dec 2021

Investigational mRNA-based HIV vaccine shows promise in mice and non-human primates

An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates, according to scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

9 Dec 2021

Report helps understand how inequalities hinder the fight against HIV, tuberculosis and malaria

Inequities have been widely acknowledged as barriers to achieving global and national goals and targets in HIV, TB and malaria programs. However, the magnitude and extent of underlying health inequalities have remained poorly documented and understood.

9 Dec 2021

Study reveals the role of intracellular receptor PQBP1 in response to Tau protein

Just as a home security system can alert a homeowner to the presence of an intruder, a protein called polyglutamine binding protein-1 (PQBP1) found in brain cells can alert the body to the presence of "intruding" viruses like human immunodeficiency virus (HIV).

9 Dec 2021

Immune responses against SARS-CoV-2 Delta variant after BNT162b2 vaccination in people living with HIV

Researchers from Sorbonne Universite have been investigating the effect of the BNT162b2 mRNA vaccine on HIV-positive individuals.

9 Dec 2021

Increased risk of COVID-19 breakthrough infections in fully vaccinated people with HIV

New study results showed a 41% greater incidence of breakthrough infections in people with HIV compared to that of people without HIV.

9 Dec 2021

Characterization of the baseline SARS-CoV-2 S-reactive B cell repertoire

Researchers from the University Of Amsterdam have identified several oddities in unvaccinated individuals' antibody response to the spike protein.

8 Dec 2021

Study: Healthcare workers need to understand the impact of shame on HIV patients to improve treatment

Ensuring healthcare workers better understand the psychological, social and physical impacts of shame on HIV patients will help improve their medical treatment, a study argues.

8 Dec 2021

Meth use and intimate partner violence drive exhaustion of immune cells in HIV patients

A study of HIV-positive black and Latino men who have sex with men finds the use of methamphetamine combined with intimate partner violence boosted the activity of genes that regulate the body's inflammatory and antiviral functions

6 Dec 2021

'Combination' adjuvant may boost the protective power of vaccines

Scientists at La Jolla Institute for Immunology and Massachusetts Institute of Technology, have found a possible way to improve the effectiveness of COVID-19 vaccines-;and any vaccine.

4 Dec 2021

New nanoparticle adjuvant could help make vaccines more powerful

A common strategy to make vaccines more powerful is to deliver them along with an adjuvant -; a compound that stimulates the immune system to produce a stronger response.

3 Dec 2021

Children and other patients in Africa missed vital medical appointments due to COVID-19

Patients seeking treatment for HIV, malaria, tuberculosis, maternal and child health services missed vital appointments because of the pressures COVID-19 put on Africa's health systems, new research has found.

2 Dec 2021

In-depth analysis of SARS-CoV-2 specific T cells in unexposed individuals

A new study aimed to analyze SARS-CoV-2 specific T-cells in unexposed individuals.

2 Dec 2021

Study suggests efficacy of SARS-CoV-2 main protease inhibitors is not compromised in current COVID-19 variants

A new study has focussed on assessing the Mpro mutants of newly emerged SARS-CoV-2 variants.

2 Dec 2021

Study analyzes global COVID-19 vaccination rates among people living with HIV

COVID-19 vaccination is especially important for immunocompromised individuals, such as people living with HIV, who face higher risks of developing severe symptoms and dying from COVID-19.

1 Dec 2021

New analysis highlights the global prevalence of HIV among transgender people

A new analysis highlights the prevalence of HIV among transgender individuals worldwide, and shows the need for continued prevention efforts for this population.

1 Dec 2021

World AIDS Day: New Vital Signs report highlights persistent disparities in HIV prevention and care

Despite overall progress in reducing new infections among gay and bisexual men, the HIV epidemic continued and was more severe among Black or African American (hereafter referred to as Black) and Hispanic/Latino gay and bisexual men in the decade leading up to the federal Ending the HIV Epidemic in the U.S. (EHE) initiative, which the U.S. Department of Health and Human Services launched in 2019.

1 Dec 2021

WHO recommends the use of first long-acting option to protect women from HIV

The first long-acting option to protect women from HIV, proven to reduce women's HIV risk, has been recommended for use by the World Health Organization.

1 Dec 2021

Study uncovers major disparities in preferred HIV medication uptake in low- and middle-income countries

A new study uncovered large and persistent disparities by sex and age in the uptake of a preferred HIV medication in low- and middle-income countries, potentially subjecting some women to worse HIV treatment outcomes if the situation is not corrected quickly.

30 Nov 2021

Scientists identify a new therapeutic target for HIV

Scientists in Montreal and London have identified the key role played by transcription factorRORC2 in HIV infection: the molecule attaches itself to parts of the virus's genome yet doesn't prevent it from replicating.

30 Nov 2021

HIV News and Research

Booster vaccination can reduce breakthrough infection risk in HIV patients

Investigational mRNA-based HIV vaccine shows promise in mice and non-human primates

Report helps understand how inequalities hinder the fight against HIV, tuberculosis and malaria

Study reveals the role of intracellular receptor PQBP1 in response to Tau protein

Immune responses against SARS-CoV-2 Delta variant after BNT162b2 vaccination in people living with HIV

Increased risk of COVID-19 breakthrough infections in fully vaccinated people with HIV

Characterization of the baseline SARS-CoV-2 S-reactive B cell repertoire

Study: Healthcare workers need to understand the impact of shame on HIV patients to improve treatment

Meth use and intimate partner violence drive exhaustion of immune cells in HIV patients

'Combination' adjuvant may boost the protective power of vaccines

New nanoparticle adjuvant could help make vaccines more powerful

Children and other patients in Africa missed vital medical appointments due to COVID-19

In-depth analysis of SARS-CoV-2 specific T cells in unexposed individuals

Study suggests efficacy of SARS-CoV-2 main protease inhibitors is not compromised in current COVID-19 variants

Study analyzes global COVID-19 vaccination rates among people living with HIV

New analysis highlights the global prevalence of HIV among transgender people

World AIDS Day: New Vital Signs report highlights persistent disparities in HIV prevention and care

WHO recommends the use of first long-acting option to protect women from HIV

Study uncovers major disparities in preferred HIV medication uptake in low- and middle-income countries

Scientists identify a new therapeutic target for HIV

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News